Abstracts Archive - Page 1842 of 2425 - ACR Meeting Abstracts

Abstract Number: 2297 • 2015 ACR/ARHP Annual Meeting
Dinamyx Neuromodulation in Fibromyalgia
CAMILLO GIACOMELLI, Antonino Santagati, Arianna Consensi, Alessandra Rossi and Laura Bazzichi, Division of Reumatology, Univeristy of Pisa, Pisa, Italy
Background/Purpose: Fibromyalgia (FM) is one of the most common diseases manifested by pain, tenderness and fatigue. FM is still a disorder of unknown etiology that…
Abstract Number: 2298 • 2015 ACR/ARHP Annual Meeting
Misdiagnosis of Fibromyalgia (FM) As Axial Spondylarthritis (SpA): Lessons from Analysis of 26 Cases
Dongfeng Liang, Jianglin Zhang and Feng Huang, Rheumatology, Chinese PLA General Hospital, Beijing, China
Background/Purpose: Both patients with fibromyalgia (FM) and with axial spondyloarthritis (SpA) are suffering from pain. The patients with axial SpA are mainly manifested as inflammatory…
Abstract Number: 2299 • 2015 ACR/ARHP Annual Meeting
Association Between Catechol-O-Methyl Transferase Gene Polymorphisms and Fibromyalgia in a Korean Population: A Case-Control Study
Yi-Rang Yim¹, Dong-Jin Park², Seong-Ho Kim³, Seong-Su Nah⁴, Ji Hyun Lee⁵, Seong-Kyu Kim⁶, Yeon-Ah Lee⁷, Seung-Jae Hong⁸, Hyun-Sook Kim⁹, Hye-Soon Lee¹⁰, Hyoun-Ah Kim¹¹, Chung-Il Joung¹², Sang-Hyon Kim¹³ and Shin-Seok Lee¹, ¹Chonnam National University Medical School and Hospital, Gwangju, South Korea, ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, ³Inje University Haeundae Paik Hospital, Busan, South Korea, ⁴Soonchunhyang University, College of Medicine, Cheonan, South Korea, ⁵Internal Medicine, Maryknoll Medical Center, Busan, South Korea, ⁶Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, ⁷Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea, ⁸Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, South Korea, ⁹Internal Medicine, College of Medicine, Chosun University, Gwangju, South Korea, ¹⁰Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ¹¹Ajou University Hospital, Suwon, South Korea, ¹²Internal Medicine, Konyang University Medical School, Daejeon, South Korea, ¹³Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea
Background/Purpose: Although polymorphisms of the catechol-O-methyl transferase (COMT) gene have been implicated in altered pain sensitivity, results concerning the association between COMT gene polymorphisms and…
Abstract Number: 2300 • 2015 ACR/ARHP Annual Meeting
Polymorphisms of Transient Receptor Potential Vanilloid (TRPV) 2 and TRPV3 Gene Polymorphisms Were Associated with Fibromyalgia in a Korean Population
Yi-Rang Yim¹, Dong-Jin Park², Seong-Ho Kim³, Seong-Su Nah⁴, Ji Hyun Lee⁵, Seong-Kyu Kim⁶, Yeon-Ah Lee⁷, Seung-Jae Hong⁸, Hyun-Sook Kim^9,10, Hye-Soon Lee¹¹, Hyoun-Ah Kim¹², Chung-Il Joung¹³, Sang-Hyon Kim¹⁴ and Shin-Seok Lee¹, ¹Chonnam National University Medical School and Hospital, Gwangju, South Korea, ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, ³Inje University Haeundae Paik Hospital, Busan, South Korea, ⁴Soonchunhyang University, College of Medicine, Cheonan, South Korea, ⁵Internal Medicine, Maryknoll Medical Center, Busan, South Korea, ⁶Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, ⁷Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea, ⁸Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, South Korea, ⁹Internal Medicine, College of Medicine, Chosun University, Gwangju, South Korea, ¹⁰Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University of Korea, Seoul, South Korea, ¹¹Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ¹²Ajou University Hospital, Suwon, South Korea, ¹³Internal Medicine, Konyang University Medical School, Daejeon, South Korea, ¹⁴Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea
Background/Purpose: Fibromyalgia (FM) is a chronic pain syndrome characterized by lowered pain thresholds and other FM-related symptoms such as fatigue, anxiety and depression. Recent studies…
Abstract Number: 2301 • 2015 ACR/ARHP Annual Meeting
Facing Fibromyalgia; How Patients Describe Their Symptoms Based on a Retrospective Evaluation of a Patient Survey and Vitality Assessment in Clinical Trials
Andrew Clair¹, Lynne Pauer² and Elizabeth Masters¹, ¹Pfizer Inc., New York, NY, ²Pfizer Inc, New London, CT
Background/Purpose: Fibromyalgia (FM) is a common chronic widespread pain disorder with comorbid symptoms of fatigue, sleep disturbance, cognitive dysfunction and depression. It is believed to…
Abstract Number: 2302 • 2015 ACR/ARHP Annual Meeting
The Impact of Prior Fibromyalgia Treatment on the Response to Pregabalin in Fibromyalgia Clinical Trials
Lynne Pauer¹, Andrew Clair², Pritha Bhadra Brown², Marie Ortiz² and Joseph Scavone¹, ¹Pfizer Inc, Groton, CT, ²Pfizer Inc., New York, NY
Background/Purpose: Fibromyalgia (FM) is a chronic, widespread pain disorder for which Lyrica is an approved treatment. Antidepressants, gabapentin, muscle relaxants, and opioids are frequently used…
Abstract Number: 2303 • 2015 ACR/ARHP Annual Meeting
Psychometrics of Online Administration of Fibromyalgia Impact Questionnaire – Revised
Scott M. Mist¹ and Kim Jones², ¹Office of Research & Development, Oregon Health & Science University, Portland, OR, ²Rsch & Develop/Mail Code SN OR, Oregon Health Sciences Univ, Portland, OR
Background/Purpose: The Fibromyalgia Impact Questionnaire – Revised (FIQR) [1] has been in wide use since Bennett et al revised the original FIQ[2]. While the instrument…
Abstract Number: 2304 • 2015 ACR/ARHP Annual Meeting
Clinical, Ultrasonographic and Neurophysiological Correlation of Patients with Carpal Tunnel Syndrome in Santo Domingo, Dominican Republic
Ismely Paulino and Paulino-Izquierdo I, Paula-Mateo J, MS. Adames, Medrano-Sánchez J, Peña-Blanco R, Muñoz-Louis R, Rosario V, T. Valdez-Lorie, R. Alba-Fériz, Rheumatology, Hospital Docente Padre Billini, Santo Domingo, Dominican Republic
Background/Purpose: Carpal Tunnel Syndrome (CTS) is produced by the entrapment of the median nerve (MN) in the carpal tunnel. It is characterized by pain and…
Abstract Number: 2305 • 2015 ACR/ARHP Annual Meeting
Relationship Between Anxiety, Depression, Sleep, Fibromyalgia and BMI in Patients with Rheumatic Disease
Shazia Bég¹ and Ali Ahmad², ¹Rheumatology, University of Central Florida, Orlando, FL, ²University of Central Florida, Orlando, FL
Background/Purpose: Patients with rheumatic diseases often have comorbidities that complicate their psychological well-being and affect prognosis. In this study, we looked at 216 patients with…
Abstract Number: 2306 • 2015 ACR/ARHP Annual Meeting
Prevalence of Fibromyalgia in Inflammatory Rheumatic Disease. Single-Center Cross-Sectional Study in 691 Patients
Angélique Fan¹, Anne Tournadre², Bruno Pereira³, Zuzana Tatar¹, Marion Couderc¹, Sylvain Mathieu⁴, Martin Soubrier¹ and Jean-Jacques Dubost¹, ¹Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, ²Rheumatology, UNH-UMR 1019 INRA University of Auvergne and Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, ³Biostatistics unit (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France, ⁴Rheumatology Department, CHU clermont-Ferrand, Clermont-Ferrand, France
Background/Purpose: Fibromyalgia (FM) is a prevalent syndrome in patients with inflammatory rheumatic disease. The purpose of this study was to evaluate and compare the prevalence…
Abstract Number: 2307 • 2015 ACR/ARHP Annual Meeting
Relationship of Sleep Quality and Fibromyalgia Outcomes in a Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of Bedtime, Rapidly Absorbed, Sublingual Cyclobenzaprine (TNX-102 SL)
Harvey Moldofsky¹, R Michael Gendreau², Daniel J. Clauw³, Judith Gendreau⁴, Benjamin Vaughn⁵, Bruce Daugherty⁴, Amy Forst⁶, Gregory Sullivan⁷ and Seth Lederman⁸, ¹Ctr for Sleep & Chronobiology, Centre for Sleep/Chronobiology, Toronto, ON, Canada, ²Gendreau Consulting LLC, Poway, CA, ³Anesthesiology, University of Michigan, Ann Arbor, MI, ⁴Tonix Pharmaceuticals, New York, NY, ⁵Statistics, Rho, Chapel Hill, NC, ⁶Clinical Development, Tonix Pharmaceuticals, San Jose, CA, ⁷Clinical Development, Tonix Pharmaceuticals, NEW YORK, NY, ⁸Research and Development, Tonix Pharmaceuticals, Inc., New York, NY
Background/Purpose: The importance of nonrestorative sleep in the pathophysiology of fibromyalgia (FM) suggests that treatments that improve sleep quality would address global symptoms. TNX-102 SL1a…
Abstract Number: 2308 • 2015 ACR/ARHP Annual Meeting
Responder Compared to Mean Change Analyses in a Fibromyalgia Phase 2b Clinical Study of Bedtime Rapidly Absorbed Sublingual Cyclobenzaprine (TNX-102 SL)
R Michael Gendreau¹, Daniel J. Clauw², Judith Gendreau³, Bruce Daugherty³ and Seth Lederman⁴, ¹Gendreau Consulting LLC, Poway, CA, ²Anesthesiology, University of Michigan, Ann Arbor, MI, ³Tonix Pharmaceuticals, New York, NY, ⁴Research and Development, Tonix Pharmaceuticals, Inc., New York, NY
Background/Purpose: Fibromyalgia (FM) is characterized by symptoms that include widespread pain and sleep disruption. Clinical studies that rely on patient self-reported outcome measures such as pain…
Abstract Number: 2309 • 2015 ACR/ARHP Annual Meeting
Bedtime, Rapidly Absorbed Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia: Results of a Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
Seth Lederman¹, R Michael Gendreau², Daniel J. Clauw³, Lesley M. Arnold⁴, Judith Gendreau⁵, Bruce Daugherty⁵ and Amy Forst⁶, ¹Research and Development, Tonix Pharmaceuticals, Inc., New York, NY, ²Gendreau Consulting LLC, Poway, CA, ³Anesthesiology, University of Michigan, Ann Arbor, MI, ⁴Psychiatry, University of Cincinnati, Cincinnati, OH, ⁵Tonix Pharmaceuticals, New York, NY, ⁶Clinical Development, Tonix Pharmaceuticals, San Jose, CA
Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain and sleep disturbance. Treatments that improve sleep quality in FM patients may improve fibromyalgia by a…
Abstract Number: 2310 • 2015 ACR/ARHP Annual Meeting
Evaluation of Fibromyalgia Syndrome in Patients Undergoing Peritoneal Dialysis
Taskin Senturk¹, Gokhan Sargin² and Hakan Akdam³, ¹Rheumatology, Adnan Menderes University School of Medicine, Aydin, Turkey, ²Rheumatology, Adnan Menderes University Rheumatology, Aydin, Turkey, ³Nephrology, Adnan Menderes University, Nephrology, Aydin, Turkey
Background/Purpose: Fibromyalgia syndrome (FMS) is characterized by widespread pain, fatigue, memory problems. The syndrome is present in about %2-8 of general population. However, knowledge about this…
Abstract Number: 2311 • 2015 ACR/ARHP Annual Meeting
Safety of Pregabalin for Treatment of Fibromyalgia Is Comparable Between Subjects with Moderate or Severe Baseline Widespread Pain
Andrew Clair¹ and Birol Emir², ¹Pfizer Inc, New York, NY, ²Primary Care Business Unit, Pfizer Global Research and Development, New York, NY
Background/Purpose: Pregabalin has demonstrated efficacy and safety for the treatment of pain associated with fibromyalgia (FM) and is approved by the US Food and Drug…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].